An oral fluid drug test collects saliva from the mouth using an absorbent swab device, screens for drugs of abuse at the point of collection, and — where the screen is non-negative — sends the sample to a NATA-accredited laboratory for confirmation under AS 4760:2019. The method detects use within the preceding 4–24 hours for most substances, making it the standard of care for post-incident, for-cause, and random testing in safety-critical Australian workplaces.
Why oral fluid has displaced urine testing in many Australian programs
Ten years ago, urine was the default. Today, most post-incident and for-cause testing in mining, construction, transport, and energy is conducted by oral fluid. The shift happened for three practical reasons, not ideological ones.
First, the detection window. Urine can detect cannabis metabolites for up to 30 days in regular users — meaning a positive urine test after a workplace incident may reflect weekend use that had no bearing on the worker’s state at the time of the incident. Oral fluid detects THC for 4–24 hours in most adults. That’s the window that matters when you’re trying to understand what happened on a particular shift.
Second, adulteration. Urine collection requires a private cubicle, and the specimen is out of sight during voiding. Workers motivated to beat a test can add water, bleach, or commercially available masking products. Oral fluid collection is directly witnessed — the collector watches the swab in the mouth for the entire collection period. There is no credible adulteration method for oral fluid that doesn’t simply prevent collection.
Third, procedural dignity. Oral fluid collection is less intrusive for both the worker and the collector. It requires no private facilities and can be conducted on-site in a vehicle, in a field office, or at a portable testing station.
How an oral fluid drug test works — from collection to result
The procedure under AS 4760:2019 has seven defined stages. Each one matters for chain of custody. Skipping or compressing steps is the primary reason results are challenged successfully in Fair Work proceedings.
Identity verification and consent documentation
The collector verifies the worker's identity against photo ID, confirms the policy trigger that applies (random selection, post-incident, for-cause, or pre-employment), records the date, time, and collection ID, and ensures the worker has signed the chain of custody form. A copy of the policy should be available at this point.
Pre-collection mouth check
The collector checks for food, gum, tobacco, or anything else in the mouth. The worker should not have eaten, drunk, smoked, or placed anything in their mouth for at least 10 minutes before collection. If they have, a 10-minute wait is observed before proceeding.
Witnessed swab collection
The swab device is placed in the worker's mouth and moved around — typically between the cheek and lower gum — for the device's specified collection period (usually 3–5 minutes). The collector watches the entire procedure. The worker does not touch the device. Adequate sample volume is confirmed by a saturation indicator on the device.
Point-of-collection screen
The device processes the sample and produces a preliminary screen result, typically within 3–8 minutes. A negative screen (no drug detected above cutoff) is recorded and the worker is cleared. A non-negative result triggers the confirmation pathway.
Split sample preservation for non-negative results
For any non-negative screen, a portion of the oral fluid sample is transferred into a laboratory specimen tube, sealed in the worker's presence, labelled with the chain of custody ID, and prepared for laboratory dispatch. The worker signs the sealed specimen packaging.
NATA-accredited laboratory confirmation
The sealed specimen is transported to a NATA-accredited laboratory within the AS 4760:2019 stability requirements (typically within 24–48 hours at refrigerated temperature). The laboratory uses LC-MS/MS analysis to confirm the presence and concentration of the specific substance, applying the AS 4760:2019 confirmation cutoff levels. The result is reported by the laboratory to the medical review officer (MRO) or nominated contact.
Medical review officer (MRO) review for positive confirmations
A confirmed positive result should be reviewed by an MRO — an occupational physician or occupational health practitioner trained in MRO assessment. The MRO contacts the worker to determine whether there is a legitimate medical explanation (e.g., prescribed opioids) before the positive result is released to the employer. Skipping MRO review for confirmed positives is legally problematic and may constitute a breach of the Privacy Act 1988.
Detection windows for common substances
Detection windows vary by substance, individual metabolism, and frequency of use. These are approximate ranges under AS 4760:2019 cutoff levels for a single-use event in an infrequent user.
| Substance | Oral fluid window | Urine window (comparison) |
|---|---|---|
| Cannabis (THC) | 4–24 hours | 3–30 days (dose-dependent) |
| Methamphetamine | 24–72 hours | 3–5 days |
| MDMA (ecstasy) | 24–48 hours | 2–4 days |
| Cocaine | 12–24 hours | 2–4 days |
| Morphine / heroin | 12–24 hours | 2–3 days |
| Oxycodone | 24–48 hours | 2–4 days |
| Benzodiazepines | 12–24 hours | 3–7 days (up to 30 for long-acting) |
Detection windows are approximate and vary significantly with frequency of use, dose, hydration, and individual metabolism. Regular high-frequency users may test positive well beyond these single-use ranges.
The regulatory and standards framework
Australia does not have a single national workplace drug testing Act. Instead, the framework assembles from four sources: general WHS obligations, industry-specific regulations, standards, and employment law.
AS 4760:2019
The primary technical standard governing oral fluid testing in Australia. Specifies collection procedures, point-of-collection device performance criteria, laboratory confirmation cutoffs, chain of custody documentation, and reporting requirements. If your program does not reference AS 4760:2019, its results are not defensible in a contested employment proceeding.
Work Health and Safety Act 2011 (model WHS Act)
The employer's primary duty of care under s19 of the WHS Act — to ensure the health and safety of workers so far as is reasonably practicable — is the legal basis for a workplace drug and alcohol program. The employer's obligation to manage impairment risk in safety-critical roles is what justifies the intrusion of drug testing on privacy grounds.
Fair Work Act 2009
Employment consequences arising from a positive test (stand-down, disciplinary process, dismissal) must comply with the Fair Work Act 2009 unfair dismissal provisions. A dismissal following a positive drug test is defensible where the policy existed, was communicated, was applied consistently, the result was confirmed by a NATA laboratory, MRO review occurred, and the worker was given an opportunity to respond.
Privacy Act 1988 and Australian Privacy Principles
Drug test results are sensitive health information under the Privacy Act 1988. They must be collected only for the purpose disclosed, stored securely, disclosed only to authorised parties (typically HR and the worker's direct supervisor chain on a need-to-know basis), and not retained longer than required by the organisation's records policy. The MRO review step is partly a Privacy Act requirement — it prevents the employer from receiving raw clinical data without a clinical filter.
Disability Discrimination Act 1992
Workers with a diagnosed substance use disorder have a disability under the DDA. An employer who dismisses a worker solely on the basis of a positive test result, without considering whether the underlying condition can be managed with reasonable adjustment (such as a rehabilitation program with monitoring), may face a discrimination complaint. This does not mean substance use disorders are protected from safety consequences — it means the employer must demonstrate they considered adjustment options before taking adverse action.
Oral fluid or urine — which to choose for each trigger type
Both methods are valid under Australian standards. The choice should be driven by the purpose of the test, not historical habit or contract terms with a collection provider.
Post-incident testing
Recommended: Oral fluid
Shorter detection window focuses on the state of the worker at the time of the incident. A positive urine result at 72 hours post-incident for cannabis may not establish impairment at the time. Oral fluid is more probative for the question at hand.
For-cause / reasonable suspicion
Recommended: Oral fluid
Speed of collection and result (3–8 minutes for screen) is important when you have a worker presenting with concerning behaviour. The witnessed collection is also more procedurally secure in a situation where the worker may be motivated to adulterate.
Random testing
Recommended: Oral fluid or urine
Both are appropriate for random programs. Some organisations use oral fluid for random testing because it requires no private collection facilities. Others maintain urine-based random programs where the broader detection window is seen as a stronger deterrent. Policy consistency matters more than the method choice.
Pre-employment screening
Recommended: Urine (typically)
Pre-employment testing often aims to identify recent drug use patterns rather than day-of impairment. The broader urine detection window captures more recent history. Some organisations use oral fluid for pre-employment to avoid the logistical complexity of urine collection at screening clinics.
Return-to-duty monitoring
Recommended: Oral fluid
Where a worker is returning from a rehabilitation program with a monitoring agreement, oral fluid testing provides meaningful recent-use data. A 30-day urine positive for cannabis does not tell you whether the worker used in the past 48 hours or three weeks ago.
Regulatory / licence requirement
Recommended: Check the applicable regulation
Rail, aviation, and maritime sectors have specific regulatory requirements that may prescribe the specimen type. The National Road Transport Heavy Vehicle legislation references fatigue and impairment but does not mandate a specific collection method. Always check the current industry-specific regulation before selecting a method.
How to act on a positive result without creating an adverse action risk
A confirmed positive oral fluid result is the beginning of a process, not the end of one. The steps below reflect current Fair Work Commission and Federal Court guidance on defensible post-positive procedure.
Stand the worker down safely
Remove the worker from safety-critical duties immediately on a non-negative screen result. This is not a disciplinary step — it is a safety measure. The worker should be stood down on pay pending confirmation. Document the stand-down decision and the safety basis for it.
Wait for laboratory confirmation
Do not take disciplinary action on a screen result alone. Non-negative screens have false positive rates. A worker dismissed on a screen result that is subsequently not confirmed has a strong unfair dismissal claim. AS 4760:2019 specifies that confirmation must precede reporting a positive result to the employer for action.
Complete MRO review
The MRO reviews the confirmed positive result, contacts the worker regarding prescribed medication, and determines whether a legitimate medical explanation exists. If one does, the result is reported as negative. If not, the positive is reported to the employer. The MRO step is the clinical and privacy firewall between the laboratory and the employer.
Conduct a show cause process
The worker must be given an opportunity to respond to the confirmed positive result before any disciplinary decision is made. This includes the right to a support person or union representative. The show cause process is a Fair Work Act 2009 procedural requirement. Omitting it is grounds for an unfair dismissal finding even where the substantive policy breach is established.
Apply the graduated response in the policy
Most defensible drug and alcohol policies have a graduated response: first confirmed positive triggers referral to EAP or rehabilitation with monitoring; second event triggers formal disciplinary process; third or serious event (e.g., positive in a safety-critical situation causing injury) may trigger termination. Applying the policy consistently is the single most important factor in Fair Work Commission outcomes.
Frequently asked questions
What drugs does an oral fluid test detect?
Australian Standard AS 4760:2019 specifies the primary drug classes for oral fluid testing: cannabis (THC), methamphetamine and amphetamines, cocaine and benzoylecgonine, opioids (including morphine, codeine, and oxycodone), and MDMA. Some workplace programs also include benzodiazepines and buprenorphine. The screen detects recent-use metabolites present in saliva — it does not detect alcohol, which requires a separate breath or blood test.
How long does oral fluid testing detect cannabis use?
THC is detectable in oral fluid for approximately 4–24 hours after use in most adults, though this varies with frequency of use, hydration, and individual metabolism. This is significantly shorter than urine testing (which can detect cannabis metabolites for 3–30 days depending on use frequency). The shorter detection window means oral fluid is better suited to identifying recent impairment rather than past use — making it the preferred method for post-incident and for-cause testing under AS 4760:2019.
Is oral fluid drug testing admissible evidence under Australian law?
Oral fluid tests conducted and reported under AS 4760:2019 produce results that are recognised as evidence in Australian employment proceedings, coronial inquiries, and WHS regulatory actions. The standard specifies chain of custody requirements, laboratory confirmation cutoffs, and reporting protocols that make the results defensible. Point-of-collection devices used for initial screening are preliminary results only — a non-negative screen must be confirmed by a NATA-accredited laboratory before disciplinary action is taken. Bypassing laboratory confirmation is the single most common reason drug test results fail in contested employment proceedings.
Can a worker refuse an oral fluid drug test at work?
Where the drug and alcohol policy is a condition of employment, is referenced in the enterprise agreement or employment contract, and the direction to test is reasonable and follows policy procedure, a worker who refuses may be treated as if they returned a non-negative result under most Australian policies. The employer must ensure the policy was communicated, that a copy was accessible to the worker, and that the direction followed the policy trigger (e.g., post-incident, random selection, reasonable suspicion). A refusal treated as a positive must still follow the same graduated response process as an actual positive result. Workers retain the right to have a support person present during the procedure.
What is the difference between AS 4760:2019 and AS 4308:2023 for drug testing?
AS 4760:2019 (Procedures for specimen collection and the detection and quantitation of drugs of abuse in oral fluid) governs oral fluid drug testing — the collection procedure, the point-of-collection device criteria, the laboratory confirmation cutoffs, and the chain of custody requirements for saliva samples. AS 4308:2023 (Procedures for specimen collection and the detection and quantitation of drugs of abuse in urine) governs urine drug testing with an equivalent scope. Both are published by Standards Australia and referenced by Safe Work Australia as the applicable technical standards for Australian workplace drug testing programs. An employer who references one standard in their policy should ensure their collection and laboratory procedures are aligned to that standard specifically.
Does a positive oral fluid result mean the worker was impaired at work?
Not necessarily. A confirmed positive oral fluid result means the worker had a detectable concentration of a drug above the cutoff level at the time of collection. It does not, by itself, establish clinical impairment. Impairment depends on the drug, the concentration, individual tolerance, and the task demands. The result establishes a breach of the workplace policy (which prohibits the presence of drugs above cutoffs, not impairment per se). In jurisdictions and workplaces where impairment — rather than mere presence — must be established to support a serious disciplinary outcome, a medical review officer (MRO) assessment and sometimes additional clinical observation evidence may be required.
Drug & Alcohol Testing — OccuSpan Service
AS 4760:2019 compliant oral fluid and urine testing, MRO review, and chain of custody management.
Fitness for Work Assessment
When post-incident testing leads to a broader fitness for duty assessment.
Pre-Employment Screening Guide
Drug screening as part of an IROJ-calibrated pre-employment program.
Managing Psychosocial Hazards at Work
Substance use risk sits within the broader psychosocial hazard framework under ISO 45003:2021.
OccuSpan
Drug and alcohol testing — collected, confirmed, and documented to AS 4760:2019
OccuSpan manages the full chain of custody from collection to MRO review, with audit-ready records that are defensible in Fair Work and WHS regulatory proceedings.
See drug & alcohol testing